The AJMC® clinical page includes all the published content across AJMC.com, The American Journal of Managed Care® and Evidence-Based Oncology™ on a variety of specialties, including dermatology, cardiology, oncology, and rheumatology.
July 11th 2025
Glucagon-like peptide-1 (GLP-1) receptor agonists significantly enhance overall survival in patients with ovarian cancer, offering a promising adjunct to traditional treatments.
New Digital Tool to Compare Insurance Coverage for Cancer Screening Tests
November 8th 2016The Prevent Cancer Foundation has developed a digital tool that can compare coverage of screening tests for breast, cervical, colorectal, lung, and prostate cancers across health insurance plans available in a specific state.
Read More
Meta-Analysis Confirms Clinical Advantage of BRAF/MEK and PD-1 Inhibitors in Melanoma
November 7th 2016Based on a retrospective meta-analysis of clinical trial data, authors of a recent paper in JAMA Oncology concluded that BRAF/MEK and programmed death receptor-1 (PD-1) inhibitors were the most effective treatments that were relatively safe in melanoma.
Read More
US Economic Burden Attributable to Adult Vaccine-Preventable Diseases Estimated at $9 Billion
November 6th 2016Low rates of vaccination among US adults result in preventable diseases and costs to individuals and society in terms of deaths, disabilities, and economic losses from hospitalizations, lost income, and physician visits.
Read More
Ted Kyle Emphasizes a Greater Need for Obesity Education for Employers
November 3rd 2016Obesity is more than just a lifestyle disease. Ted Kyle, RPh, MBA, principal at ConscienHealth, explained that understanding its complexities as well as the behavioral and physical care it requires is essential in improving the health and productivity of employees.
Watch
What We're Reading: Despite California Law, Women Struggle to Access Birth Control
November 1st 2016What we're reading, November 1, 2016: despite law, women in California still struggle to access birth control; Americans mostly believe obesity can be fixed through willpower; and Facebook is going after pharmaceutical advertisements.
Read More